Literature DB >> 23400857

The spectrum of movement disorders in children with anti-NMDA receptor encephalitis.

José Fidel Baizabal-Carvallo1, Amber Stocco, Eyal Muscal, Joseph Jankovic.   

Abstract

BACKGROUND: Movement disorders are frequent but difficult to characterize in patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
METHODS: The phenomenology of movement disorders was characterized after a detailed examination of children with anti-NMDAR-encephalitis.
RESULTS: We studied 9 children (5 females), ages 3-14 years, with confirmed anti-NMDAR-encephalitis. All patients presented with at least 1 movement disorder, including chorea (n=4), stereotypic movements (n=4), ataxia (n=3), limb dystonia (n=2), limb myorhythmia (n=2), oromandibular dystonia (n=2), facial myorhythmia, blepharospasm, opisthotonus, athetosis, and tremor (n=1, each). More than a single movement disorder was observed in 6 of these patients. Resolution of the abnormal movements was observed in all patients with immunotherapy; 1 patient improved with tetrabenazine.
CONCLUSIONS: A wide variety of movement disorders, often in combination, can be observed in children with anti-NMDAR encephalitis. Patients commonly present with more than a single movement disorder.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400857     DOI: 10.1002/mds.25354

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  What is specialized care in status epilepticus and in which ICU?

Authors:  Sophie Demeret; Nicolas Weiss; Francis Bolgert; Vincent Navarro
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

2.  Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.

Authors:  Maarten J Titulaer; Frank Leypoldt; Josep Dalmau
Journal:  Mov Disord       Date:  2013-11-04       Impact factor: 10.338

3.  When a serum test overrides the clinical assessment.

Authors:  Thaís Armangue; Joan Santamaria; Josep Dalmau
Journal:  Neurology       Date:  2015-02-27       Impact factor: 9.910

4.  Myorhythmia-Like Dyskinesia Affecting the Face and Ear Associated With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Ana Camacho; Noemí Núñez; Thaís Armangué; Rogelio Simón
Journal:  Mov Disord Clin Pract       Date:  2015-12-24

Review 5.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

6.  A Case Study in the History of Neurology.

Authors:  Gregory S Day; David F Tang-Wai; Michel C F Shamy
Journal:  Neurohospitalist       Date:  2016-05-27

Review 7.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

8.  Magnetic resonance imaging findings in patients presenting with (sub)acute cerebellar ataxia.

Authors:  Tanja Schneider; Götz Thomalla; Einar Goebell; Anna Piotrowski; David Mark Yousem
Journal:  Neuroradiology       Date:  2015-02-17       Impact factor: 2.804

Review 9.  [Update on anti-N-methyl-D-aspartate receptor encephalitis].

Authors:  S Kovac; J Alferink; D Ahmetspahic; V Arolt; N Melzer
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

Review 10.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.